“An Unusual Skin Adverse Event After Switching from Intravenous to Subcutaneous VEDOLIZUMAB Therapy in Patients With Ulcerative Colitis”. Archives of Clinical and Medical Case Reports 7, no. 1 (February 10, 2023): 77–79. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22706.